What amount sold does Kantum Pharma, Inc. report in Form D filings?

The latest linked filings report $5.3M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Kantum Pharma, Inc.'s most recent SEC filing?

Kantum Pharma, Inc.'s most recent Form D filing was on 2021-07-13.

How many investors does Kantum Pharma, Inc. have?

The most recent Form D filing lists 44 investor(s).

What type of securities does Kantum Pharma, Inc. offer?

Kantum Pharma, Inc.'s SEC Form D filings indicate equity offerings.

Kantum Pharma, Inc.

CIK: 0001747673·Biotechnology·CONCORD, NH·Corporation

Reported Sold

$5,324,887

Total Filings

Identified Offerings

Last Filed

Jul 13, 2021

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jul 13, 2021Form D — New notice

Reported sold: $3,530,522 · Target: $3,530,522

Rule 506(b)·44 investors

Oct 12, 2018Form D — New notice

Reported sold: $805,000 · Target: $2,000,000

Rule 506(b)·11 investors

Jul 24, 2018Form D — New notice

Reported sold: $989,365 · Target: $1,500,000

Rule 506(b)·26 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 3 identified offerings

$5,324,887

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Sylvie Breton

Related Person

Appears on 3 filings

Glenn Batchelder

Related Person

Appears on 2 filings

Rachel Liberman

Related Person

Appears on 2 filings

Leileata Russo

Related Person

Appears on 2 filings

Andrea Franz

Related Person

Appears on 2 filings

Jean-Francois Carbonneau

Related Person

Appears on 2 filings

Glenn Batchelder

Related Person

Appears on 1 filing

Thomas Needham

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 13, 2021	New	$3,530,522	$3,530,522	44
Oct 12, 2018	New	$2,000,000	$805,000	11
Jul 24, 2018	New	$1,500,000	$989,365	26

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Swep Bio, Inc.

Biotechnology

Offering target: $4,999,976

Filed Oct 29, 2026